Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Bio-Rad Laboratories; Idaho Technology; Prognosys; Massachusetts Life Sciences Center

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories today said that it has extended its pending offer to exchange any and all of its outstanding 8 percent Senior Subordinated Notes due 2016 that were issued in a private placement for 8 percent Senior Subordinated Notes due 2016.

The firm commenced the offer at the end of December. It said today that $299,980,000 aggregate principal amount of the private notes out of the total $300 million have been received to date. The offer has now been extended to expire on Feb. 4.


Idaho Technology this week announced that his begun clinical trials for its FilmArray Respiratory Panel at three US hospital laboratories. The FilmArray RP is a molecular diagnostic test that identifies 21 common respiratory viruses and bacteria. The firm said that it has integrated sample preparation and can report results in less than an hour.


Prognosys, a startup developing barcode diagnostics, this week announced that it has joined the University of Maryland's Maryland Technology Enterprise Institute Technology Advancement Program incubator. The firm, which was founded in 2007, is developing its first product — a test for multiple cardiovascular diseases built on Prognosys' barcode platform — with support from a $100,000 phase I grant from the National Heart, Lung and Blood Institute.


The Massachusetts Life Sciences Center, a quasi-public agency that is charged with implementing the state's $1 billion Life Sciences Initiative, this week launched a new Small Business Matching Grant program that will match federal small business grant funding for early-stage life science firms. It said $3 million would be made available for this program in 2010. Applicants can begin applying for the grants on Feb. 1 on the center's website.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.